Skip to main content

Clifford Chance

Clifford Chance
All
Briefings

Briefings

In this section

Compulsory licensing and new provisions affecting IP holders during the Coronavirus crisis in France and globally

20 April 2020

Pharmaceutical companies and screening test manufacturers are facing new major challenges due to the global health crisis relating to the coronavirus (COVID-19).

To strike the right balance between the interests of rights holders, third parties and the public, exceptions and limitations to patent rights have been promulgated in France and abroad.

Download PDF
  • Share on Twitter
  • Share on LinkedIn
  • Share via email
Back to top

Toolkits & Client Log-in